Digital Diagnostics and Mobile Health in Laboratory Medicine: An International Federation of Clinical Chemistry and Laboratory Medicine Survey on Current Practice and Future Perspectives
    
Yazarlar (11)
Frank Desiere Roche Diagnostics International Ltd, İsviçre
Katarzyna Kowalik Roche Diagnostics International Ltd, İsviçre
Christian Fassbind Roche Diagnostics International Ltd, İsviçre
Ramy Samir Assaad Alexandria University, Mısır
Anna K. Füzéry Alberta, Kanada
Damien Gruson Cliniques Universitaires Saint-Luc, Belçika
Michael Heydlauf Siemens Healthineers, Amerika Birleşik Devletleri
Kazuhiko Kotani Jichi Medical University, Japonya
James H. Nichols Vanderbilt University School Of Medicine, Amerika Birleşik Devletleri
Doç. Dr. Zihni Onur UYGUN Kafkas Üniversitesi, Türkiye
Bernard Gouget Healthcare Division Committee, Fransa
Makale Türü Açık Erişim Özgün Makale (ESCI dergilerinde yayınlanan tam makale)
Dergi Adı Journal of Applied Laboratory Medicine
Dergi ISSN 2475-7241 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler Emerging Sources Citation Index
Makale Dili İngilizce Basım Tarihi 07-2021
Cilt / Sayı / Sayfa 6 / 4 / 969–979 DOI 10.1093/jalm/jfab026
Makale Linki http://dx.doi.org/10.1093/jalm/jfab026
Özet
Background: A survey of IFCC members was conducted to determine current and future perspectives on digital innovations within laboratory medicine and healthcare sectors. Methods: Questions focused on the relevance of digital diagnostic solutions, implementation and barriers to adopting digital technologies, and supplier roles in supporting innovation. Digital diagnostic market segments were defined by solution recipient (laboratory, clinician, patient/consumer, payor) and proximity to core laboratory operations. Results: Digital solutions were of active interest for >90% of respondents. Although solutions to improve core operations were ranked as the most relevant currently, a future shift to technologies beyond core laboratory expertise is expected. A key area of potential differentiation for laboratory customers was clinical decision support. Currently, laboratories collaborate strongly with suppliers of laboratory integration software and information systems, with high expectations for future collaboration in clinical decision support, disease self-management, and population health management. Asia Pacific countries attributed greater importance to adopting digital solutions than those in other regions. Financial burden was the most commonly cited challenge in implementing digital solutions. Conclusions: Specialists in laboratory medicine are proactively approaching digital innovations and transformation, and there is high enthusiasm and expectation for further collaboration with suppliers and healthcare professionals beyond current core laboratory expertise.
Anahtar Kelimeler
Digital diagnostics | Digitalization | Laboratory digital technologies | Laboratory medicine | Mobile health